CD93, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD93, Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD93, Human |
| Clone | VIMD2 |
| Host Species | Mouse |
| Reactive Species | human, nonhuman primate |
| Isotype | IgG1κ |
| Format | allophycocyanin (APC) conjugate |
| Size | 100 tests in 1 mL |
| Concentration | 1:11 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD93 Antibody, anti-human, APC. The monoclonal antibody VIMD2 reacts with human CD93, also known as C1qRp, which is a 120 kDa heavily O-glycosylated protein. It is expressed on myeloid cells, platelets, endothelial cells, and immature dendritic cells whereas mature dendritic cells show weak to negative CD93 expression. C1qRp is involved in regulation of phagocytic activity, macrophage activation, and cell-cell adhesion. |
| Immunogen | n/a |
| Other Names | C1QR1, C1qR(P), C1qRp, CDw93, ECSM3, MXRA4, dJ737E23.1 |
| Gene, Accession # | Gene ID: 22918 |
| Catalog # | 130-098-441 |
| Price | $325 |
| Order / More Info | CD93, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Nepomuceno, R. R. and Tenner, A. J. (1998) C1qRP, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets. J Immunol 160: 1929-1935. | Nepomuceno, R. R. et al. (1999) C1qRP Is a heavily O-glycosylated cell surface protein involved in the regulation of phagocytic activity. J Immunol 162: 3583-3589. | Steinberger, P. et al. (2002) Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning. J. Leukoc. Biol. 71: 133-140. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies